P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 196 200 KRW -1.85% Market Closed
Market Cap: 2T KRW
Have any thoughts about
PharmaResearch Co Ltd?
Write Note

Net Margin
PharmaResearch Co Ltd

30.6%
Current
27%
Average
-7.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
30.6%
=
Net Income
90.7B
/
Revenue
296.6B

Net Margin Across Competitors

Country KR
Market Cap 2T KRW
Net Margin
31%
Country FR
Market Cap 6T USD
Net Margin
-21 040%
Country US
Market Cap 314.7B USD
Net Margin
9%
Country US
Market Cap 147.4B USD
Net Margin
13%
Country US
Market Cap 119.4B USD
Net Margin
-5%
Country US
Market Cap 113.8B USD
Net Margin
0%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country AU
Market Cap 135.4B AUD
Net Margin
18%
Country US
Market Cap 82.6B USD
Net Margin
34%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country NL
Market Cap 34.3B EUR
Net Margin
-14%
No Stocks Found

PharmaResearch Co Ltd
Glance View

Market Cap
2T KRW
Industry
Biotechnology

PharmaResearch Co., Ltd. engages in the research and development of refined raw materials for cell and tissue regeneration through marine bio technology. The company is headquartered in Gangneung, Gangwon-Do. The company went IPO on 2015-07-24. The firm produces and sells regenerated products such as pharmaceuticals, medical devices, and cosmetics. In addition, the Company is involved in the venture investment and real estate leasing. The firm mainly provides its products in domestic market.

Intrinsic Value
250 092.53 KRW
Undervaluation 22%
Intrinsic Value
Price
P

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
30.6%
=
Net Income
90.7B
/
Revenue
296.6B
What is the Net Margin of PharmaResearch Co Ltd?

Based on PharmaResearch Co Ltd's most recent financial statements, the company has Net Margin of 30.6%.